Javier Szwarcberg
- Pulmonary and Respiratory Medicine top 0.5%
- Infectious Diseases top 1%
- Virology top 0.5%
- Physiology top 2%
- Epidemiology top 10%
- Co-authors
- Paul W. NobleCarlo AlberaDominique ValeyreUlrich CostabelTalmadge E. KingWilliamson Z. BradfordLisa LancasterRoland M. du Bois
- Topics
- HIV/AIDS drug development and treatment (29 papers)HIV Research and Treatment (23 papers)HIV/AIDS Research and Interventions (14 papers)
- Journals
- The LancetAmerican Journal of Respiratory and Critical Care MedicineClinical Infectious Diseases
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Javier Szwarcberg
47 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Pulmonary and Respiratory Medicine 2.4k
- Infectious Diseases 1.4k
- Virology 1.0k
- Physiology 806
- Epidemiology 453
Countries citing papers authored by Javier Szwarcberg
This map shows the geographic impact of Javier Szwarcberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Szwarcberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Szwarcberg more than expected).
Fields of papers citing papers by Javier Szwarcberg
This network shows the impact of papers produced by Javier Szwarcberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Szwarcberg. The network helps show where Javier Szwarcberg may publish in the future.
Co-authorship network of co-authors of Javier Szwarcberg
This figure shows the co-authorship network connecting the top 25 collaborators of Javier Szwarcberg. A scholar is included among the top collaborators of Javier Szwarcberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Szwarcberg. Javier Szwarcberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 62 | |
| 2 | 67 | |
| 3 | 17 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 11 | |
| 7 | 21 | |
| 8 | 17 | |
| 9 | 84 | |
| 10 | 1 | |
| 11 | 33 | |
| 12 | 97 | |
| 13 | 335 | |
| 14 | 133 | |
| 15 | 256 | |
| 16 | Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsbreakdown → | 1478 |
| 17 | 297 | |
| 18 | 330 | |
| 19 | 371 | |
| 20 | 2 |
About Javier Szwarcberg
Javier Szwarcberg is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 48 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (23 papers) and HIV/AIDS Research and Interventions (14 papers). The work is most often cited by research in Virology (1.0k citations), Pulmonary and Respiratory Medicine (2.4k citations) and Infectious Diseases (1.4k citations). Javier Szwarcberg has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Paul W. Noble, Carlo Albera, Dominique Valeyre, Ulrich Costabel, Talmadge E. King, Williamson Z. Bradford, Lisa Lancaster, Roland M. du Bois, Steven A. Sahn and David Kardatzke. Their work appears in journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.